CWC Breaks Ground on ATCC Biomanufacturing Facility in Manassas, VA.
Governor Youngkin, Dr. Cypess, and Prince William County officials celebrate the groundbreaking of ATCC's new facility
ATCC Expands Footprint with New Facility
We recently broke ground on a new biomanufacturing facility for ATCC Biomanufacturing Facility world’s largest general cultural collection, at their headquarters in Manassas, Virginia. The ceremony was attended by Virginia Governor Glenn Youngkin, ATCC Chairman and CEO Dr. Raymond H. Cypess, Virginia Secretary of Commerce and Trade Caren Merrick, and members of the Prince William Board of County Supervisors (BOCS).
The facility will strengthen the nation's capacity to quickly respond to future pandemics, bolster global health efforts, and protect national security by guaranteeing access to essential biological materials. As a reliable partner in life sciences, ATCC will lead research on emerging infectious diseases, contributing to public health protection and reducing the effects of future global health challenges.
Governor Youngkin presents a Virginia flag to ATCC Chairman & CEO Dr. Raymond Cypess
Building Big in Virginia
During his remarks, Governor Youngkin expressed his excitement “ATCC is a world-class resource for scientists performing vital research to solve important health issues. They are a crucial component to Virginia’s thriving life sciences industry, and I am thrilled to see them invest in Virginia again.”
In addition to its impact on global health needs, the new facility will have a significant local economic impact, creating 75 new jobs with an average annual salary of $92,933.
From left to right: Jason Shaw, Terrence Caulfield, x, x, Greg Harraka.
Life Sciences in the DMV
This exciting project will join our robust Life Science & Technology portfolio, which includes award-winning projects such as Kite Pharma’s TCF05 Cell Therapy Manufacturing Facility, Precision Labs, and Research Square. “We are proud to contribute to a space where the brightest minds will come together to tackle some of the most pressing challenges in healthcare and science,” said Jason Shaw, CWC’s Life Sciences expert.